ArticleAmerican journal of cancer research2026
Effectiveness and safety of recombinant human endostatin injection plus immune checkpoint inhibitors for non-small cell lung cancer: a single-centered, retrospective study.
Fei Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.